Evidence map›Paper›PMID 30145348›Full record

ArticlePreventive medicine2018

Examining the relationship between pregnancy and quitting use of tobacco products in a U.S. national sample of women of reproductive age.

Allison N Kurti, Ryan Redner, Janice Y Bunn, Katherine Tang, Tyler Nighbor, Alexa A Lopez, Diana R Keith, Andrea C Villanti, Cassandra A Stanton, Diann E Gaalema and 7 more

Abstract read
In one paragraph

Article in Preventive medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Vaping in Pregnancy: A Systematic Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Editorial: 5Preventive medicine · 2018
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Allison N KurtiVermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychiatry, University of Vermont, United States of America. Electronic address: akurti@uvm.edu.
Ryan RednerVermont Center on Behavior and Health, University of Vermont, United States of America; Rehabilitation Institute, Southern Illinois University, United States of America.
Janice Y BunnDepartment of Biostatistics, University of Vermont, United States of America.
Katherine TangVermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychiatry, University of Vermont, United States of America.
Tyler NighborVermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychiatry, University of Vermont, United States of America.
Alexa A LopezVermont Center on Behavior and Health, University of Vermont, United States of America.
Diana R KeithVermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychiatry, University of Vermont, United States of America.
Andrea C VillantiVermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychiatry, University of Vermont, United States of America.
Cassandra A StantonWestat, Center for Evaluation and Coordination of Training and Research (CECTR) in Tobacco Regulatory Science, United States of America; Department of Oncology, Georgetown University Medical Center, United States of America.
Diann E GaalemaVermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychiatry, University of Vermont, United States of America.
Nathan J DooganCenter of Excellence in Regulatory Tobacco Science, The Ohio State University, United States of America.
Antonio Cepeda-BenitoVermont Center on Behavior and Health, University of Vermont, United States of America.
Megan E RobertsCenter of Excellence in Regulatory Tobacco Science, The Ohio State University, United States of America.
Julie PhillipsVermont Center on Behavior and Health, University of Vermont, United States of America; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Vermont, United States of America.
Maria A ParkerVermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychiatry, University of Vermont, United States of America.
Amanda J QuisenberryCenter of Excellence in Regulatory Tobacco Science, The Ohio State University, United States of America.
Stephen T HigginsVermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychiatry, University of Vermont, United States of America; Department of Psychological Science, University of Vermont, United States of America.
University of Vermont · USThe Ohio State University · USWestat (United States) · US

Funding

Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2013 to 2022
$21.3M
University of Vermont Tobacco Center of Regulatory ScienceU54DA036114 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2018 to 2022
$19.4M
Vermont Center on Tobacco Regulatory ScienceP50DA036114 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2013 to 2017
$19.1M
Project 4: Comprehension of Health Risks in More and Less Arousing Affe p240-275P50CA180908 · NCI · OHIO STATE UNIVERSITY · PI SHIELDS, PETER G., WEWERS, MARY ELLEN · 2013 to 2017
$18.9M
Leadership and Administrative Core (p 188-304)U54CA189222 · NCI · WESTAT, INC. · PI NIAURA, RAYMOND, ROSENTHAL, JEANNE · 2014 to 2018
$8.5M
TRAINING IN BEHAV. PHARMACOLOGY OF HUMAN DRUG DEPENDENCET32DA007242 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HEIL, SARAH H, HIGGINS, STEPHEN T · 1990 to 2025
$8.2M
Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant WomenR01HD075669 · NICHD · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2013 to 2017
$3.6M
NCI NIH HHS P50 CA180908NCI NIH HHS U54 CA189222NICHD NIH HHS R01 HD075669NIDA NIH HHS P50 DA036114NIDA NIH HHS T32 DA007242NIDA NIH HHS U54 DA036114NIGMS NIH HHS P20 GM103644
6 · The paper itself

Abstract

This study examined quit rates longitudinally for cigarettes, e-cigarettes, hookah, cigars, and all tobacco products in a U.S. national sample of women aged 18-44 who completed both Wave 1 (W1) and Wave 2 (W2) of the Population Assessment of Tobacco and Health (PATH, 2013-2014, 2014-2015) study (N = 7814). Quit rates were examined among women who transitioned into pregnancy across survey waves, and among a comparable sample of non-pregnant women to provide contextual information about quitting among the broader population of reproductive-aged women. Multiple logistic regression modeling was used to estimate the associations of pregnancy and quitting adjusting for other demographic and psychosocial characteristics. Quit rates among women who were pregnant in W2 were highest for hookah (98.3%), followed by cigars (88.0%), e-cigarettes (81.3%), and lowest for tobacco cigarettes (53.4%). Slightly more than half (58.7%) of women reported quitting use all tobacco products while pregnant. Pregnancy was independently associated with increased odds of quitting hookah (AOR = 52.9, 95%CI = 3.4, 830.2), e-cigarettes (AOR = 21.0, 95%CI = 2.6, 170.3), all tobacco products (AOR = 9.6, 95%CI = 6.4, 14.5), and cigarettes (AOR = 6.5, 95%CI = 4.2, 10.1), although not cigars. Relative to other demographic and psychosocial characteristics, pregnancy was the strongest predictor of quitting use of each tobacco product. While these data indicate that pregnancy has strong, independent associations with quitting a variety of commercially available tobacco products, the comparatively lower quit rates for cigarettes versus other tobacco products underscores the long-standing need for more intensive, multipronged clinical and regulatory interventions to reduce cigarette use among reproductive-aged women.

Indexed as

AdolescentAdultCigarette SmokingElectronic Nicotine Delivery SystemsEthnicityFemaleHumansPregnancySurveys and QuestionnairesTobacco ProductsTobacco Use CessationUnited StatesYoung AdultCigarette smokingCigarsE-cigaretteHookahNationally representative sampleNicotinePopulation Assessment of Tobacco and HealthPregnancyQuittingTobacco

Identifiers

PMID30145348
PMCPMC6195821
OpenAlexW2888081164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.